News

Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.
NEW YORK – A team led by investigators at Institut Pasteur has commenced work on a new lateral flow assay that could be used to detect the presence of the malaria-causing parasite Plasmodium vivax in ...
Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds outpace prior hauls.
Among other impacts, the committee's closure could hamper efforts to modernize CLIA regulations, which has been a priority among many in the clinical lab space.
Last week, readers were most interested in a story about Accelerate Diagnostics' issues leading up to its bankruptcy filing.
Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke ...
Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...
The partners will study the use of a test for Ly6E(hi) neutrophils as a biomarker for treatment response in five cancer indications.
The test, which aids in the detection of the brain amyloid pathology characteristic of Alzheimer's, is the first blood test cleared by FDA for use in diagnosing the disease.
The lateral flow, fingerprick blood test measures monoclonal proteins, with results that can be read on a phone app.
NEW YORK – Targeted Genomics on Wednesday announced a commercial collaboration with OraSure Technologies for direct-to-consumer celiac disease testing using the OraCollect-Dx saliva collection device ...
The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.